Publicaciones

CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer and melanoma.
Andrea Moreno Manuel, Eloisa Jantus Lewintre, Ines Simões, Fernando Aranda, Silvia Calabuig Fariñas, Esther Carreras,
Sheila Zúñiga, Yvonne Saenger, Rafael Rosell, Carlos Camps, Francisco Lozano, Rafael Sirera.
Publicación aceptada.
Tipo de publicación: Artículo.
Revista: Translational Lung Cancer Research.
Factor de impacto: 4.806.
Cuartil: Q1.
dPCR application in liquid biopsies: divide and conquer.
Moreno-Manuel A, Calabuig-Fariñas S, Obrador-Hevia A, Blasco A, Fernández-Díaz A, Sirera R, Camps C, Jantus-Lewintre E.Expert Rev Mol Diagn. 2021 Jan;21(1):3-15.
Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor–positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment.
Provencio M, Serna-Blasco R, Franco F, Calvo V, Royuela A, Auglytė M, Sánchez-Hernández A, de Julián Campayo M, García-Girón C, Dómine M, Blasco A, Sánchez JM, Oramas J, Bosch-Barrera J, Sala MÁ, Sereno M, Ortega AL, Chara L, Hernández B, Padilla A, Coves J, Blanco R, Balsalobre J, Mielgo X, Bueno C, Jantus-Lewintre E, Molina-Vila MÁ, Romero A.. European Journal of Cancer 149 (2021) 61e7262.
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project.
Finn SP, Addeo A, Dafni U, Thunnissen E, Bubendorf L, Madsen LB, Biernat W, Verbeken E, Hernandez-Losa J, Marchetti A, Cheney R, Warth A, Speel EM, Quinn AM, Monkhorst K, Jantus-Lewintre E, Tischler V, Marti N, Dimopoulou G, Molina-Vila MA, Kammler R, Kerr KM, Peters S, Stahel RA; European Thoracic Oncology Platform Lungscape Investigators. J Thorac Oncol. 2021 Feb 26:S1556-0864(21)01734-2.
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial. 
Romero A, Jantus-Lewintre E, García-Peláez B, Royuela A, Insa A, Cruz P, Collazo A, Pérez Altozano J, Vidal OJ, Diz P, Cobo M, Hernández B, Vázquez Estevez S, Benítez G, Guirado M, Majem M, Bernabé R, Ortega AL, Blasco A, Bosch-Barrera J, Jurado JM, García González J, Viteri S, Garcia Giron C, Massutí B, Lopez Martín A, Rodriguez-Festa A, Calabuig-Fariñas S, Molina-Vila MÁ, Provencio M. Mol Oncol. 2021 Jan;15(1):43-56.
Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma.
Herreros-Pomares A, Llorens C, Soriano B, Bagan L, Moreno A, Calabuig-Fariñas S, Jantus-Lewintre E, Bagan J. Oral Oncol. 2021 Feb 28;116:105191.
3D printing novel in vitro cancer cell culture model systems for lung cancer stem cell study.
Herreros-Pomares A, Zhou X, Calabuig-Fariñas S, Lee SJ, Torres S, Esworthy T, Hann SY, Jantus-Lewintre E, Camps C, Zhang LG. Mater Sci Eng C Mater Biol Appl. 2021 Mar;122:111914.
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer.
Moreno-Manuel A, Jantus-Lewintre E, Simões I, Aranda F, Calabuig-Fariñas S, Carreras E, Zúñiga S, Saenger Y, Rosell R, Camps C, Lozano F, Sirera R. Transl Lung Cancer Res. 2020 Aug;9(4):1074-1083.
Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications
Camps C, López R, Antón A, Aranda E, Carrato A, Cruz JJ, Cunquero-Tomás AJ, Díaz-Rubio E, Feyjóo M, García-Foncillas J, Gascón P, Lugo I, Rogado Á, Guillem V. JCO Oncol Pract. 2021 Feb 23:OP2000683.
Update on systemic treatment in early triple negative breast cancer. 
Núñez Abad M, Calabuig-Fariñas S, Lobo de Mena M, José Godes Sanz de Bremond M, García González C, Torres Martínez S, García-García JÁ, Iranzo González-Cruz V, Camps Herrero C. Ther Adv Med Oncol. 2021 Jan 31;13:1758835920986749
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB). 
Rolfo C, Cardona AF, Cristofanilli M, Paz-Ares L, Diaz Mochon JJ, Duran I, Raez LE, Russo A, Lorente JA, Malapelle U, Gil-Bazo I, Jantus-Lewintre E, Pauwels P, Mok T, Serrano MJ; ISLB.Crit Rev Oncol Hematol. 2020 Jul;151:102978.
A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer
Torres S, González Á, Cunquero Tomas AJ, Calabuig Fariñas S, Ferrero M, Mirda D, Sirera R, Jantus-Lewintre E, Camps C. Expert Rev Mol Diagn. 2020 Jun;20(6):575-582.
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019).
Dómine M, Moran T, Isla D, Martí JL, Sullivan I, Provencio M, Olmedo ME, Ponce S, Blasco A, Cobo M. Clin Transl Oncol. 2020 Feb;22(2):245-255.
Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study.
Fernandez-Serra A, Moura DS, Sanchez-Izquierdo MD, Calabuig-Fariñas S, Lopez-Alvarez M, Martínez-Martínez A, Carrasco-Garcia I, Ramírez-Calvo M, Blanco-Alcaina E, López-Reig R, Obrador-Hevia A, Alemany R, Gutierrez A, Hindi N, Poveda A, Lopez-Guerrero JA, Martin-Broto J. Cancers (Basel). 2020 Oct 14;12(10):2979.
Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q. 
Song Y, Jia Z, Wang Y, Wang Y, Liu P, Zhang S, Bing Z, Cao L, Cao Z, Rossi E, Zamarchi R, Denis MG, Camps C, Fernandez-Diaz AB, Liang N, Li S. J Thorac Dis. 2020 May;12(5):2771-2780.
Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients. 
Mondelo-Macía P, Rodríguez-López C, Valiña L, Aguín S, León-Mateos L, García-González J, Abalo A, Rapado-González O, Suárez-Cunqueiro M, Díaz-Lagares A, Curiel T, Calabuig-Fariñas S, Azkárate A, Obrador-Hevia A, Abdulkader I, Muinelo-Romay L, Diaz-Peña R, López-López R.Cells. 2020 Feb 24;9(2):522.
Detection of the EGFR G719S Mutation in Non-small Cell Lung Cancer Using Droplet Digital PCR.
Esteva-Socias M, Enver-Sumaya M, Gómez-Bellvert C, Guillot M, Azkárate A, Marsé R, Sastre Ú, Blasco A, Calabuig-Fariñas S, Asensio VJ, Terrasa J, Obrador-Hevia A. Front Med (Lausanne). 2020 Nov 13;7:594900.